MDMA and magic mushrooms reconsidered for rescheduling by Therapeutic Goods Administration

Alex Crowe
Updated April 18 2021 - 10:42am, first published 4:00am

An application to make MDMA and psilocybin more easily accessible to psychiatrists for mental health treatments will now be independently reviewed following an earlier rejection.

Subscribe now for unlimited access.


(min cost $0)

or signup to continue reading

See subscription options
Alex Crowe

Alex Crowe

Science and Environment Reporter

Alex covers science and environment issues, with a focus on local Canberra stories.

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.